国产大屁股熟女免费视频_久久精品毛片免费卡_中国免费xxxx视频在线观看_亚洲色视频福利在线观看

[China Pharmaceutical Network Market Analysis] On July 12, the Ministry of Industry and Information Technology released the "Completion of Major Economic Indicators of the Pharmaceutical Industry in 2015" and "Completion of Major Economic Indicators of the Pharmaceutical Industry from January to April 2016". It can be seen from the data that, no matter from the analysis of main business or profit analysis, the chemical pharmaceutical preparation manufacturing industry accounts for the largest proportion in the pharmaceutical industry.

(Chemical preparations account for the largest proportion of the pharmaceutical industry, taking the lead. Image source: Baidu image)

According to the statistical bulletin and related statistical information, the completion of the main economic indicators of the pharmaceutical industry from January to April in 2015 and 2016 is as follows:

In 2015, the added value of the pharmaceutical industry above designated size increased by 9.8% year-on-year, and the growth rate was 2.7 percentage points lower than the previous year, which was 3.7 percentage points higher than the overall industrial growth rate. The added value of the pharmaceutical industry accounted for 3.0% of the overall industrial added value, an increase of about 0.2% over the previous year, reflecting that the pharmaceutical industry has further increased its contribution to overall industrial growth.

From January to April, the added value of the pharmaceutical industry above designated size increased by 9.6% year-on-year, and the growth rate was 1.1 percentage points lower than the same period last year, which was 3.8 percentage points higher than the overall industrial growth rate. The added value of the pharmaceutical industry accounted for 3.3 in the overall industry.

1. Main business income

From the perspective of main business income, according to the ranking of sub-industry, they are chemical pharmaceutical preparation manufacturing, Chinese patent medicine manufacturing, chemical raw material medicine manufacturing, biological medicine manufacturing, medical equipment and equipment manufacturing, sanitary materials and medical supplies manufacturing, and Chinese herbal medicine decoction pieces. Processing and pharmaceutical machinery manufacturing.

In 2015, enterprises above designated size in the pharmaceutical industry realized revenue from main operations of 2.688519 billion yuan, a year-on-year increase of 9.02%, which was 8.22 percentage points higher than the national industrial growth rate, but 4.42 percentage points lower than the previous year. Among sub-sectors, the growth rate of Chinese patent medicines and pharmaceutical equipment is lower than the industry average.

From January to April, the main business income of enterprises above designated size in the pharmaceutical industry was 867.923 billion yuan, a year-on-year increase of 10.4%, which was 8.1 percentage points higher than the overall national industrial growth rate and 0.89 percentage points higher than the same period last year. Among the various sub-sectors, the fastest growing income from main business is medical equipment and equipment, and Chinese herbal medicine.

2. Profit

Judging from the ranking of total profit, chemical medicine still tops the list, followed by Chinese patent medicine, biological medicine, raw material medicine, medical instrument and equipment manufacturing, sanitary materials and medical supplies manufacturing, Chinese herbal medicine processing, and pharmaceutical machinery manufacturing.

In 2015, the total profits of enterprises above designated size in the pharmaceutical industry reached 276.823 billion yuan, an increase of 12.22% year-on-year, 14.52% higher than the national industrial growth rate, and a decrease of 0.93% from the previous year. The annual profit growth rate was higher than the growth rate of main business income, indicating that the profitability of the pharmaceutical industry has improved.

From January to April, the total profits of enterprises above designated size in the pharmaceutical industry reached 57.678 billion yuan, a year-on-year increase of 16.3%, which was 9.8 percentage points higher than the overall national industrial growth rate and 4.66 percentage points higher than the same period last year. Among the various sub-sectors, the fastest growing profits are chemical raw materials, medical equipment and equipment, but at the same time, the profits of pharmaceutical equipment have experienced negative growth.

3. Export value

In 2015, the export delivery value of enterprises above designated size in the pharmaceutical industry was 179.85 billion yuan, a year-on-year increase of 3.6%, and the growth rate was 6.1 percentage points lower than the previous year. According to customs import and export data, the export value of pharmaceutical products in 2015 was US$56.44 billion, a year-on-year increase of 2.7%, and the growth rate was 4.7 percentage points lower than the previous year. The export structure has been improved, and the export proportion of chemical medicine preparations and medical equipment has increased.

From January to April, the export delivery value of enterprises above designated size in the pharmaceutical industry was 58.556 billion yuan, a year-on-year increase of 6.48%, and the growth rate was 1.96 percentage points higher than the same period last year.

4. Fixed asset investment

In 2015, the pharmaceutical manufacturing industry completed a fixed asset investment of 581.2 billion yuan, an increase of 11.9% year-on-year, and the growth rate was 3.2 percentage points lower than the previous year, which was 4.2 percentage points higher than the overall national industrial growth rate. While maintaining rapid growth, it reflects that the technological transformation of enterprises focusing on GMP upgrades and new plant construction since the "Twelfth Five-Year Plan" is gradually decreasing. (Source: Ministry of Industry and Information Technology Original title: The Ministry of Industry and Information Technology uses data to tell you what medicine is most profitable to sell? )